List view / Grid view

miRNAs

 

Using bioactivity profiling to support the progression of phenotypic hits

7 September 2018 | By ,

This webinar, held on 28 June 2018, illustrated the optimisation of hits derived from a target-agnostic phenotypic screen, using a strategy based on combining bioactivity profiling and reference compound characterisation. Keynote speaker Arsenio Nueda, Head of Molecular Biology at Almirall, responded as follows to questions posed during the webinar.

Using bioactivity profiling to support the progression of phenotypic hits

27 April 2018 | By Eurofins Pharma Discovery Services

In this webinar, we discussed a recent case study where a phenotypic screen was performed using poly I:C / IL-4 stimulated human bronchial epithelial cells. This resulted in the identification of 7 representative hits which provided starting points for new drug discovery opportunities.